Clinical Trials Study
Copyright ©The Author(s) 2025.
World J Hepatol. May 27, 2025; 17(5): 105890
Published online May 27, 2025. doi: 10.4254/wjh.v17.i5.105890
Table 1 Baseline characteristics of the three subgroups, n (%)
Characteristic
Reoperative laparoscopic left lateral sectionectomy (n = 40)
Reoperative laparoscopic left hemihepatectomy (n = 50)
Reoperative laparoscopic complex hepatectomy (n = 11)
χ²/F value
P value
Male9 (22.5)16 (32.0)4 (36.4)1.3330.5141
Age, mean (SD), years62.3 (11.5)61.8 (7.8)60.0 (7.7)0.2610.7712
Body mass index > 21.5 kg/m218 (45.0)25 (50.0)6 (54.5 )0.4020.8181
American Society of Anesthesiologists score 2-321 (52.5)19 (38.0)5 (45.5)1.8950.3881
Obstructive jaundice6 (15.0)11 (22.0)2 (18.2)0.7160.6991
Benign liver lesions32 (80.0)43 (86.0)9 (81.8)0.5880.7451
Number of previous surgeries > 22 (5.0)1 (2.0)0 (0.0)N/A30.706
Types of previous procedureN/A30.250
cholecystectomy29 (72.5)28 (56.0)9 (81.8)
Choledochotomy with exploration11 (27.5)19 (38.0)2 (18.0)
Hepatectomy0 (0.0)3 (6.0)0 (0.0)
Types of previous approachN/A30.789
Open surgery30 (75.0)40 (80.0)9 (81.8)
Laparoscopic surgery9 (22.5)7 (14.0)2 (18.0)
Unclear1 (2.5)3 (6.0)0 (0.0)
Interval between last two surgeriesN/A30.608
≤ 2 years3 (7.5)8 (16.0)2 (18.2)
> 2 years30 (75.0)37 (74.0)8 (72.7)
Unknown time-interval7 (17.5)5 (10.0)1 (9.1)